Drug compound preparation for treating Alzheimer's disease
A technology for Alzheimer's disease and compound preparations, applied in the field of medicine, can solve the problems of reducing drug safety and difficulty in long-term application, and achieve the effect of improving patient behavior and learning and memory functions, clear drug effects, and simple ingredients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] This embodiment provides a drug compound preparation for treating Alzheimer's disease, characterized in that: the main components of the drug compound preparation for treating Alzheimer's disease include epigallocatechin gallate and vitamin E;
[0044] Oil-soluble vitamin E is mixed with 1 volume of edible oil solution, and water-soluble EGCG is mixed with 2 volumes of distilled water; after the above two liquids are mixed, an emulsifier whose mass is 10% of the edible oil mass is added to form an oil-water mixture. Suspension, the mass fraction of EGCG is 0.1%, and the mass fraction of vitamin E is 0.3%.
[0045] The epigallocatechin gallate is a polyphenol component extracted from green tea or chemically synthesized.
[0046] The emulsifier is soybean lecithin or lecithin.
[0047] The drug compound preparation for treating Alzheimer's disease has the effect of reducing the aggregation of beta amyloid protein on D-galactose-induced Alzheimer's disease model mice. Th...
Embodiment 2
[0082] This embodiment provides a drug compound preparation for treating Alzheimer's disease, characterized in that: the main components of the drug compound preparation for treating Alzheimer's disease include epigallocatechin gallate and vitamin E;
[0083] Oil-soluble vitamin E is mixed with 1 volume of edible oil solution, and water-soluble EGCG is mixed with 2 volumes of distilled water; after the above two liquids are mixed, an emulsifier whose mass is 10% of the edible oil mass is added to form an oil-water mixture. Suspension, the mass fraction of EGCG is 0.02%, and the mass fraction of vitamin E is 0.3%.
[0084] The epigallocatechin gallate is a polyphenol component extracted from green tea or chemically synthesized.
[0085] The emulsifier is soybean lecithin or lecithin.
[0086]The drug compound preparation for treating Alzheimer's disease has the effect of reducing the aggregation of beta amyloid protein on D-galactose-induced Alzheimer's disease model mice. Th...
Embodiment 3
[0116] This embodiment provides a drug compound preparation for treating Alzheimer's disease, characterized in that: the main components of the drug compound preparation for treating Alzheimer's disease include epigallocatechin gallate and vitamin E;
[0117] Oil-soluble vitamin E is mixed with 1 volume of edible oil solution, and water-soluble EGCG is mixed with 2 volumes of distilled water; after the above two liquids are mixed, an emulsifier whose mass is 10% of the edible oil mass is added to form an oil-water mixture. Suspension, the mass fraction of EGCG is 0.2%, and the mass fraction of vitamin E is 0.3%.
[0118] The epigallocatechin gallate is a polyphenol component extracted from green tea or chemically synthesized.
[0119] The emulsifier is soybean lecithin or lecithin.
[0120] The drug compound preparation for treating Alzheimer's disease has the effect of reducing the aggregation of beta amyloid protein on D-galactose-induced Alzheimer's disease model mice. Th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com